Behind the science magazine https://www.gsk.com/en-gb/behind-the-science-magazine/ Explore innovations from inside and outside our labs. Go #BehindTheScience to see for yourself Fri, 12 Dec 2025 12:00:00 GMT Fri, 12 Dec 2025 12:00:00 GMT en Mapping disease at the cellular level: A single-cell revolution in drug discovery https://www.gsk.com/en-gb/behind-the-science-magazine/gsk-teichmann-lab-collaboration/ An innovative collaboration between Teichmann Laboratory and GSK is transforming our understanding of complex diseases. Fri, 12 Dec 2025 12:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/gsk-teichmann-lab-collaboration/ protecting patients against rsv risk https://www.gsk.com/en-gb/behind-the-science-magazine/protecting-patients-against-rsv-risk/ Adults over 50 years with certain chronic health conditions face higher risk of severe RSV symptoms. Still, RSV’s impact is underestimated. Wed, 19 Nov 2025 12:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/protecting-patients-against-rsv-risk/ 'The ever-present threat of contracting a UTI means my daily routine is ruled by measures to reduce my risk' https://www.gsk.com/en-gb/behind-the-science-magazine/uti-patient-symptoms-treatment/ LeAnn suffers from chronic UTIs. She describes what it feels like, how she tries to cut down risk and why personalised care is key. Thu, 16 Oct 2025 12:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/uti-patient-symptoms-treatment/ 'We’re innovating to help keep COPD patients out of hospital and exacerbation-free' https://www.gsk.com/en-gb/behind-the-science-magazine/copd-lung-disease-prevention-comment/ We aim to prevent exacerbations and hospitalisations in COPD patients to reduce disease burden globally Fri, 26 Sep 2025 12:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/copd-lung-disease-prevention-comment/ 'Prevention is the best medicine to stop disease before it starts' https://www.gsk.com/en-gb/behind-the-science-magazine/prevention-best-medicine-disease-patients/ Investing in prevention delivers better health outcomes for patients, is cost-effective, and boosts the economy Mon, 15 Sep 2025 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/prevention-best-medicine-disease-patients/ ‘I was the sickest anyone could ever be’: Why young people are at risk of meningitis and what needs to change to reduce it https://www.gsk.com/en-gb/behind-the-science-magazine/adolescent-risk-meningitis-prevention/ Raising disease awareness could help prevent meningitis in young adults Wed, 13 Aug 2025 12:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/adolescent-risk-meningitis-prevention/ ‘Digital biological twins and organoids might sound like sci-fi, but they’re real – and we’re using them to fight cancer’ https://www.gsk.com/en-gb/behind-the-science-magazine/organoids-digital-twin-comment/ Digital twins and organoids are being used by scientists to find solutions for patients with cancer Tue, 10 Jun 2025 12:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/organoids-digital-twin-comment/ ‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options https://www.gsk.com/en-gb/behind-the-science-magazine/blood-cancer-myeloma-myelofibrosis-feature/ Researchers are working hard to address unmet needs for patients with​ multiple​ myeloma and myelofibrosis Thu, 29 May 2025 10:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/blood-cancer-myeloma-myelofibrosis-feature/ ‘Finding the right treatment for my asthma and nasal polyps has transformed my life. I hope my experience can help others achieve the same’ https://www.gsk.com/en-gb/behind-the-science-magazine/nasal-polyps-asthma-patient-comment/ Respiratory medication has evolved, patients with asthma and CRSwNP have more options than ever Wed, 14 May 2025 12:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/nasal-polyps-asthma-patient-comment/ ‘How do we improve trust in prevention? The answer lies closer to home than you might think’ https://www.gsk.com/en-gb/behind-the-science-magazine/prevention-trust-vaccination-community/ Data from the Global Listening Project shows that community voices improve confidence in vaccinations Mon, 28 Apr 2025 12:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/prevention-trust-vaccination-community/ ‘We’re aiming to protect even more children’: Research starts on second-generation malaria vaccine to prevent most severe form of disease https://www.gsk.com/en-gb/behind-the-science-magazine/second-generation-malaria-vaccine/ Katie Ewer leads a new malaria vaccine programme by GSK that could protect more children Fri, 25 Apr 2025 12:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/second-generation-malaria-vaccine/ ‘Cancer doesn’t have to be a deadly disease – it’s our goal to make it curable’ https://www.gsk.com/en-gb/behind-the-science-magazine/cancer-chronic-manageable-disease-comment/ Advances in technology and clinical sciences have transformed cancer treatments – and the lives of patients Wed, 02 Apr 2025 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/cancer-chronic-manageable-disease-comment/ Vaccinations are not just for children: why adult immunisation is a health and economic necessity https://www.gsk.com/en-gb/behind-the-science-magazine/vaccinations-children-adult-immunisation-health-economic-benefits/ As the global population ages, innovative health policy is needed to ensure adults are vaccinated against potentially dangerous diseases. Fri, 21 Mar 2025 11:30:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/vaccinations-children-adult-immunisation-health-economic-benefits/ ‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics https://www.gsk.com/en-gb/behind-the-science-magazine/amr-antibiotics-resistance-superbugs-new-medicines/ The world needs new antibiotics to combat AMR pathogens – but too few are invested in development. Fri, 21 Mar 2025 00:45:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/amr-antibiotics-resistance-superbugs-new-medicines/ Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk https://www.gsk.com/en-gb/behind-the-science-magazine/rsv-symptoms-risks-protection/ GSK scientists spent decades researching respiratory syncytial virus to understand better how to prevent the disease Mon, 10 Mar 2025 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/rsv-symptoms-risks-protection/ ‘Long-acting therapies are no longer the future of HIV treatment – they are the now’ https://www.gsk.com/en-gb/behind-the-science-magazine/long-acting-therapies-hiv-comment/ Innovation has transformed the prospects of people living with HIV from a death sentence to a chronic, manageable condition Fri, 07 Mar 2025 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/long-acting-therapies-hiv-comment/ Is it COVID-19, flu, or RSV? The symptoms to look out for – and how to tell the difference https://www.gsk.com/en-gb/behind-the-science-magazine/covid-flu-rsv-symptoms-virus/ Preventing the spread of seasonal infections is better for individuals and the community Tue, 17 Dec 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/covid-flu-rsv-symptoms-virus/ ‘The whooping cough outbreak is a stark reminder of just how important lifelong vaccination is’ https://www.gsk.com/en-gb/behind-the-science-magazine/whooping-cough-outbreak-lifelong-vaccination/ Pertussis is an infectious respiratory disease known more commonly as ‘whooping cough’ Wed, 11 Dec 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/whooping-cough-outbreak-lifelong-vaccination/ ‘It was not something I was warned about’: Preventing permanent organ damage in patients with lupus https://www.gsk.com/en-gb/behind-the-science-magazine/intervening-early-organ-damage-lupus/ While diagnosis often comes as a relief to patients with lupus, it is only the beginning of a lifelong journey Wed, 13 Nov 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/intervening-early-organ-damage-lupus/ 78% of gynaecologic cancer patients experience challenges accessing the treatment they need, new survey shows https://www.gsk.com/en-gb/behind-the-science-magazine/gynaecologic-cancer-survey-treatment-access/ Results of a new multinational survey reveal significant barriers to treatment for patients with gynaecological cancer Tue, 12 Nov 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/gynaecologic-cancer-survey-treatment-access/ ‘Teenagers may feel invincible – but we’re at risk’: What you need to know about meningitis as post-COVID cases continue to rebound https://www.gsk.com/en-gb/behind-the-science-magazine/meningitis-cases-rebound-risks-symptoms/ Around 1 in 10 of us carry the most common cause of bacterial meningitis in our nose and throats. Here are the signs to look out for Thu, 03 Oct 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/meningitis-cases-rebound-risks-symptoms/ ‘We never think AMR is going to happen to us’: The human cost of antimicrobial resistance – and how to prevent it https://www.gsk.com/en-gb/behind-the-science-magazine/amr-prevention-antibiotics-vaccines/ As bacteria evolve to outsmart antibiotics, proactive action and preventative interventions will play a critical role Fri, 20 Sep 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/amr-prevention-antibiotics-vaccines/ ‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’ https://www.gsk.com/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/ Respiratory treatments are undergoing a sustainability transformation to reduce their impact on the environment Wed, 04 Sep 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/ ‘My cough interferes with everything’: New research could help refractory chronic cough patients after decades of depression, pain, and sleep loss https://www.gsk.com/en-gb/behind-the-science-magazine/refractory-chronic-cough-patients-symptoms/ GSK scientists are working on new areas of research that could bring relief to millions of refractory chronic cough patients Tue, 03 Sep 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/refractory-chronic-cough-patients-symptoms/ Remission could be possible for people with asthma, giving them a new outlook on life https://www.gsk.com/en-gb/behind-the-science-magazine/remission-severe-asthma-treatments-possible/ Global specialists, including GSK scientists, are applying years of expertise in asthma to aspire to clinical remission. Mon, 02 Sep 2024 00:25:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/remission-severe-asthma-treatments-possible/ 6 in 10 of adults over 50 have never heard of RSV, despite some being among those most at risk of infection https://www.gsk.com/en-gb/behind-the-science-magazine/rsv-survey-data-symptoms-risk/ RSV is a leading cause of respiratory illness in adults, yet new survey data shows many do not know it exists Mon, 02 Sep 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/rsv-survey-data-symptoms-risk/ ‘This could be a golden moment’: Is prevention the ‘medicine’ we need to end the HIV epidemic? https://www.gsk.com/en-gb/behind-the-science-magazine/prevention-medicine-hiv-epidemic/ Scientists at the forefront of the race to end the HIV/AIDS epidemic reflect on how far prevention can take us Fri, 19 Jul 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/prevention-medicine-hiv-epidemic/ 'Scientists need rich and accessible data at scale to make the best possible impact for patients’ https://www.gsk.com/en-gb/behind-the-science-magazine/chris-austin-comment-data-scale-drug-discovery/ Giving researchers access to rich biological data at scale is crucial to accelerating drug discovery. GSK's SVP of Research Tech explains Wed, 05 Jun 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/chris-austin-comment-data-scale-drug-discovery/ ‘We’ve seen an explosion in computing power’: Using AI, machine learning and data to unlock the mysteries of disease https://www.gsk.com/en-gb/behind-the-science-magazine/ai-ml-data-computing-power/ By combining deep expertise in AI and machine learning with access to rich data, scientists are unlocking new discoveries about disease Wed, 05 Jun 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/ai-ml-data-computing-power/ Advanced technology is increasing the chances of improving outcomes for cancer patients https://www.gsk.com/en-gb/behind-the-science-magazine/advanced-technology-cancer-care-oncology/ Scientific understanding of cancer has accelerated, creating a paradigm shift in the way the disease is diagnosed and treated. Thu, 30 May 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/advanced-technology-cancer-care-oncology/ ‘Global health progress is vital for millions of lives, but it isn’t going fast enough. Here’s what we need to do to get things back on track’ https://www.gsk.com/en-gb/behind-the-science-magazine/thomas-breuer-comment-global-health-progress/ Barriers to progress like climate change and AMR need to be tackled head-on to meet global health objectives Tue, 28 May 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/thomas-breuer-comment-global-health-progress/ ‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage https://www.gsk.com/en-gb/behind-the-science-magazine/asthma-copd-treatment-prevent-lung-damage/ In just one asthma or COPD attack, irreversible changes to the tissue of the lungs can occur, effectively leaving them scarred Wed, 15 May 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/asthma-copd-treatment-prevent-lung-damage/ ‘Local innovation is vital to our mission to ensure no child is left to suffer from a vaccine preventable disease’ https://www.gsk.com/en-gb/behind-the-science-magazine/child-immunisation-accelerator-comment/ Save the Children are looking for local innovators in Ethiopia and Nigeria to help come up with new ways to get vaccines to children in need Tue, 23 Apr 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/child-immunisation-accelerator-comment/ ‘It is both a strategic and a moral imperative’: Why closing the health equity gap is better for everyone https://www.gsk.com/en-gb/behind-the-science-magazine/health-equity-gap-medicine-vaccine-access/ Giving patients equal access to medicines and vaccines reduces the burden of disease in wider society and relieves healthcare services Tue, 09 Apr 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/health-equity-gap-medicine-vaccine-access/ Robots, AI, and machine learning: how smart manufacturing is getting medicines and vaccines from factories to patients faster https://www.gsk.com/en-gb/behind-the-science-magazine/smart-manufacturing-factories-uppermerion-medicines/ GSK’s facility in Upper Merion uses the latest technology to deliver medicines at speed Mon, 22 Jan 2024 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/smart-manufacturing-factories-uppermerion-medicines/ In the face of climate change, vaccines play a crucial but underestimated role https://www.gsk.com/en-gb/behind-the-science-magazine/vaccines-climate-change-health-economy/ Vaccines have revolutionised healthcare, but they could also be key to tackling global challenges like climate change, AMR and poverty Tue, 05 Dec 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/vaccines-climate-change-health-economy/ A preventative patient-centred approach is key to transforming respiratory care and relieving struggling services https://www.gsk.com/en-gb/behind-the-science-magazine/patient-centred-respiratory-prevention-asthma-copd-rsv/ Respiratory care is moving away from a one-size-fits-all approach to focus on individual patient needs and treatment goals Mon, 04 Dec 2023 00:25:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/patient-centred-respiratory-prevention-asthma-copd-rsv/ ‘Adult vaccination plays an essential role in healthy ageing, so let’s prioritise prevention and make it a new standard of care’ https://www.gsk.com/en-gb/behind-the-science-magazine/adult-vaccines-healthy-ageing-comment/ Adult immunisation can help people live longer, healthier lives and continue to make vital contributions to society Mon, 04 Dec 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/adult-vaccines-healthy-ageing-comment/ ‘It can get very serious, very quickly’: the symptoms, risks, and ways to prevent pneumonia everyone should know about https://www.gsk.com/en-gb/behind-the-science-magazine/pneumonia-symptoms-risks-vaccines-treatment/ Pneumonia is a respiratory disease spread through contact with infected droplets of saliva or mucus – and it can be deadly. Fri, 10 Nov 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/pneumonia-symptoms-risks-vaccines-treatment/ Millions of people living with chronic hepatitis B are unaware they have the virus. So why aren’t they getting diagnosed? https://www.gsk.com/en-gb/behind-the-science-magazine/chronic-hepatitis-b-stigma-discrimination-diagnosis/ Under-diagnosis of chronic hepatitis B is worrying healthcare professionals because it can lead to serious consequences over time. Mon, 06 Nov 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/chronic-hepatitis-b-stigma-discrimination-diagnosis/ ‘AI has already transformed medical innovation. Let’s not let fears of technology stop us from realising its incredible potential’ https://www.gsk.com/en-gb/behind-the-science-magazine/ai-medical-innovation-ethics-responsibility/ GSK’s leading AI experts explain how society can benefit from technology in a responsible and ethical way Wed, 18 Oct 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/ai-medical-innovation-ethics-responsibility/ Biomarker testing is helping doctors find precision treatments for patients that could dramatically improve health outcomes https://www.gsk.com/en-gb/behind-the-science-magazine/biomarker-testing-ai-tumours-hepatitis-respiratory-cancer/ Innovative techniques allow clinicians to identify patients most likely to respond to treatments for hep B, respiratory diseases and cancer. Tue, 03 Oct 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/biomarker-testing-ai-tumours-hepatitis-respiratory-cancer/ Biopharma experts believe a ‘greater exchange of skills and technology’ will deliver the best results for patients https://www.gsk.com/en-gb/behind-the-science-magazine/bio-data-wall-survey-modern-tech-healthcare/ Over 1,700 BIO attendees participated in GSK’s real-time survey in June about technology and health innovation across the industry Wed, 13 Sep 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/bio-data-wall-survey-modern-tech-healthcare/ Back to school immunity: vaccination catch-ups are needed to stop the escalation of preventable diseases in children https://www.gsk.com/en-gb/behind-the-science-magazine/child-immunity-gap-vaccination-catch-up/ Medical experts say now is the time to catch up on essential immunisation programs to ensure young people and communities are protected Tue, 12 Sep 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/child-immunity-gap-vaccination-catch-up/ New digital assessment tool could improve the lives of people living with HIV by helping healthcare professionals uncover hidden burdens https://www.gsk.com/en-gb/behind-the-science-magazine/hiv-aids-treatment-pros-digital-patient-survey/ A new PROs app could improve HIV patients' quality of life by helping clinicians identify health and treatment challenges Tue, 29 Aug 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/hiv-aids-treatment-pros-digital-patient-survey/ ‘300 million people with chronic hepatitis B are waiting to re-start their lives. This is my story of hope.’ https://www.gsk.com/en-gb/behind-the-science-magazine/hepatitis-b-patient-quote-story-functional-cure/ Parent Maureen tells of her daughter's struggles with chronic hepatitis B from infancy - and what a functional cure would mean. Mon, 24 Jul 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/hepatitis-b-patient-quote-story-functional-cure/ Scientists gain ground in centuries-long malaria struggle – but more innovation is needed to stay ahead of evolving parasites https://www.gsk.com/en-gb/behind-the-science-magazine/malaria-vaccine-children-mosquitos-single-dose-treatment/ Major advances in vaccines and treatments could mark a turning point against the deadly infectious disease malaria in endemic countries. Wed, 05 Jul 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/malaria-vaccine-children-mosquitos-single-dose-treatment/ Modern technologies are doubling the odds of scientists making life-changing medical discoveries https://www.gsk.com/en-gb/behind-the-science-magazine/new-technology-drug-targets-rna-medicine-development/ Scientists are using new technologies to speed up the drug discovery process and bring effective medicines to patients sooner. Wed, 07 Jun 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/new-technology-drug-targets-rna-medicine-development/ How representation in clinical trials improves health outcomes for women https://www.gsk.com/en-gb/behind-the-science-magazine/men-women-gender-diversity-clinical-trials/ Until recently, medicines and vaccines were mainly tested on men, which has had a detrimental effect on women’s health globally. Mon, 06 Mar 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/men-women-gender-diversity-clinical-trials/ Age-related decline in immunity: why does it matter and what can be done about it? https://www.gsk.com/en-gb/behind-the-science-magazine/age-related-decline-immunity-infectious-disease/ While ageing immune systems can make people more susceptible to disease, this is especially true for COVID-19, shingles, influenza and RSV. Fri, 24 Feb 2023 00:25:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/age-related-decline-immunity-infectious-disease/ ‘I had never experienced anything like it’: the pain, risks, and first symptoms of shingles every adult should know https://www.gsk.com/en-gb/behind-the-science-magazine/shingles-symptoms-risks-pain-adults/ Presenter Eamonn Holmes shares his experience with shingles – a disease caused by the Varicella Zoster Virus, which also causes chickenpox Fri, 24 Feb 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/shingles-symptoms-risks-pain-adults/ ‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine development https://www.gsk.com/en-gb/behind-the-science-magazine/maps-technology-new-age-vaccine-development-infectious-diseases/ Researchers are testing new ways to protect against infectious disease – and pursuing effective vaccines that have eluded them for decades. Mon, 09 Jan 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/maps-technology-new-age-vaccine-development-infectious-diseases/ The ‘tripledemic’ will hit older people hard this winter - but we can reduce the impact https://www.gsk.com/en-gb/behind-the-science-magazine/tripledemic-flu-covid-rsv-older-patients-infectious-disease/ The flu, COVID-19, and RSV are all in circulation, raising the risk of severe infectious disease in older adults. Wed, 04 Jan 2023 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/tripledemic-flu-covid-rsv-older-patients-infectious-disease/ Cancer recurrence: harnessing tumour DNA to detect new growth https://www.gsk.com/en-gb/behind-the-science-magazine/cancer-recurrence-tumour-ctdna-technology/ Circulating tumour DNA technology (ctDNA) could help doctors identify when a patient's cancer has returned faster than traditional methods. Mon, 05 Dec 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/cancer-recurrence-tumour-ctdna-technology/ Antibiotic resistance https://www.gsk.com/en-gb/behind-the-science-magazine/antibiotic-resistance-now-s-the-time-to-prevent-the-next-pandemic/ Antibiotics are a cornerstone of modern healthcare Tue, 22 Nov 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/antibiotic-resistance-now-s-the-time-to-prevent-the-next-pandemic/ Using new science to get ahead of myelofibrosis - a rare blood cancer https://www.gsk.com/en-gb/behind-the-science-magazine/using-new-science-to-get-ahead-of-blood-cancer-myelofibrosis/ Myelofibrosis is a serious blood cancer that involves the build-up of excessive scar tissue in the bone marrow. Fri, 18 Nov 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/using-new-science-to-get-ahead-of-blood-cancer-myelofibrosis/ Getting ahead of COPD exacerbations using new tech could save lives https://www.gsk.com/en-gb/behind-the-science-magazine/copd-exacerbations-respiratory-disease-new-technology/ We speak to GSK respiratory disease leads David Lipson and Chris Compton about identifying future COPD patients and tailoring treatments Tue, 15 Nov 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/copd-exacerbations-respiratory-disease-new-technology/ The logic of biologic medicines: advancing care for people with immune-mediated conditions https://www.gsk.com/en-gb/behind-the-science-magazine/the-logic-of-biologic-medicines/ Biologic medicines are evolving what treatment can potentially achieve for the millions affected by immune-mediated conditions. Wed, 09 Nov 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/the-logic-of-biologic-medicines/ Eosinophils could be holding the missing link https://www.gsk.com/en-gb/behind-the-science-magazine/eosinophils-could-be-holding-the-missing-link/ Exploring the possibilities of what eosinophil science can offer to patients Thu, 01 Sep 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/eosinophils-could-be-holding-the-missing-link/ Time for a change: personalising asthma treatment https://www.gsk.com/en-gb/behind-the-science-magazine/time-for-a-change-personalising-asthma-treatment/ Asthma is different for every person and different personalised treatment approaches are needed Thu, 25 Aug 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/time-for-a-change-personalising-asthma-treatment/ Unlocking the power of the immune system https://www.gsk.com/en-gb/behind-the-science-magazine/unlocking-the-power-of-the-immune-system-to-get-ahead-of-hepatitis-b/ GSK’s innovation team have developed a longer-lasting, more effective treatment for this global health problem Wed, 22 Jun 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/unlocking-the-power-of-the-immune-system-to-get-ahead-of-hepatitis-b/ Tackling tomorrow’s health challenges today https://www.gsk.com/en-gb/behind-the-science-magazine/tackling-tomorrow-s-health-challenges-today/ Our Chief Scientist, Rino Rappuoli, explains how science is helping create the vaccines of tomorrow Mon, 30 May 2022 00:45:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/tackling-tomorrow-s-health-challenges-today/ Digital twin https://www.gsk.com/en-gb/behind-the-science-magazine/digital-twin-using-advanced-technology-to-accelerate-vaccine-development/ Embracing digitalisation is central to GSK’s new commitments to vaccine innovation Mon, 30 May 2022 00:40:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/digital-twin-using-advanced-technology-to-accelerate-vaccine-development/ Synthetic Lethality https://www.gsk.com/en-gb/behind-the-science-magazine/synthetic-lethality-accelerating-precision-cancer-treatments/ Synthetic Lethality: accelerating precision cancer treatments Mon, 30 May 2022 00:35:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/synthetic-lethality-accelerating-precision-cancer-treatments/ The 40 year fight against HIV https://www.gsk.com/en-gb/behind-the-science-magazine/the-40-year-fight-against-hiv/ How to find a treatment for a disease with no idea what that disease actually is Mon, 30 May 2022 00:30:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/the-40-year-fight-against-hiv/ Next generation of immuno-oncology https://www.gsk.com/en-gb/behind-the-science-magazine/how-the-next-generation-of-immuno-oncology-could-help-us-get-ahead-of-cancer/ We may have the potential to change our approach to cancer as we know it Mon, 30 May 2022 00:25:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/how-the-next-generation-of-immuno-oncology-could-help-us-get-ahead-of-cancer/ 1.4 million reasons to get ahead of gynaecologic cancers https://www.gsk.com/en-gb/behind-the-science-magazine/14-million-reasons-to-get-ahead-of-gynaecologic-cancers/ Tania Small discusses our approach to R&D, including the pursuit of innovative treatments Mon, 30 May 2022 00:20:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/14-million-reasons-to-get-ahead-of-gynaecologic-cancers/ How vaccine science can help tackle antimicrobial resistance https://www.gsk.com/en-gb/behind-the-science-magazine/how-vaccine-science-can-help-tackle-antimicrobial-resistance/ Without effective treatments, these infections can remain, grow, and continue to spread to other areas of the body Mon, 30 May 2022 00:15:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/how-vaccine-science-can-help-tackle-antimicrobial-resistance/ What if remission were the target of lupus care? https://www.gsk.com/en-gb/behind-the-science-magazine/what-if-remission-were-the-target-of-lupus-care/ GSK’s Dr Roger Levy explains how a Treat-to-Target could improve outcomes in patients with lupus Mon, 30 May 2022 00:10:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/what-if-remission-were-the-target-of-lupus-care/ Tech for T-cells https://www.gsk.com/en-gb/behind-the-science-magazine/tech-for-t-cells-single-cell-rna-seq-measures-shifts-in-immune-cells-to-pinpoint-causes-of-disease/ GSK’s groundbreaking research with Open Targets means far more effective treatments for immune diseases Thu, 26 May 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/tech-for-t-cells-single-cell-rna-seq-measures-shifts-in-immune-cells-to-pinpoint-causes-of-disease/ Why we’re introducing Shingles Awareness Week https://www.gsk.com/en-gb/behind-the-science-magazine/why-we-re-introducing-shingles-awareness-week/ Shingles is most common for people over 50 Tue, 17 May 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/why-we-re-introducing-shingles-awareness-week/ Targeting treatable traits https://www.gsk.com/en-gb/behind-the-science-magazine/targeting-treatable-traits-in-asthma-and-other-respiratory-conditions/ Targeting certain treatable traits an individual may exhibit could have a significant impact on their quality of life Wed, 06 Apr 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/targeting-treatable-traits-in-asthma-and-other-respiratory-conditions/ Computational Biology https://www.gsk.com/en-gb/behind-the-science-magazine/computational-biology-setting-the-stage-for-future-wins-and-new-medicines/ How new technological advances are allowing us to keep pace with genetic information Thu, 17 Mar 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/computational-biology-setting-the-stage-for-future-wins-and-new-medicines/ How we're getting ahead of an incurable blood cancer https://www.gsk.com/en-gb/behind-the-science-magazine/how-were-getting-ahead-of-an-incurable-blood-cancer/ How improvements in identifying novel drug discovery targets has greatly improved survival rates for the disease Mon, 07 Mar 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/how-were-getting-ahead-of-an-incurable-blood-cancer/ Fresh insights could finally help us tackle RSV https://www.gsk.com/en-gb/behind-the-science-magazine/fresh-insights-could-finally-help-us-tackle-rsv/ The 60 year search for solutions for RSV Fri, 11 Feb 2022 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/fresh-insights-could-finally-help-us-tackle-rsv/ AI and ML power better predictions for patient impact https://www.gsk.com/en-gb/behind-the-science-magazine/ai-and-ml-power-better-predictions-for-patient-impact/ Making better predictions: Using the power of AI-ML to give us the insights needed for better medicines + vaccines Wed, 03 Nov 2021 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/ai-and-ml-power-better-predictions-for-patient-impact/ Following the science of oxygen https://www.gsk.com/en-gb/behind-the-science-magazine/following-the-science-of-oxygen-to-discover-solutions-for-anaemia/ Targeting certain treatable traits an individual may exhibit could have a significant impact on their quality of life Tue, 02 Nov 2021 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/following-the-science-of-oxygen-to-discover-solutions-for-anaemia/ How adjuvants boost our immune response https://www.gsk.com/en-gb/behind-the-science-magazine/how-adjuvants-boost-our-immune-response/ With its name derived from the Latin for 'help', an adjuvant can boost our immune response Thu, 21 Oct 2021 00:25:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/how-adjuvants-boost-our-immune-response/ Could tiny bubbles pave the way for new technology https://www.gsk.com/en-gb/behind-the-science-magazine/could-tiny-bubbles-released-from-bacteria-cells-pave-the-way-for-new-vaccine-technology/ Advances in vaccine development as a result of COVID-19 has led to greater innovation for treating diseases across the board Thu, 21 Oct 2021 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/could-tiny-bubbles-released-from-bacteria-cells-pave-the-way-for-new-vaccine-technology/ Getting ahead of infectious diseases https://www.gsk.com/en-gb/behind-the-science-magazine/getting-ahead-of-infectious-diseases-with-advanced-technology/ The predictive power of genetics, genomics, and AI holds the key to transforming medical discovery for the better Thu, 23 Sep 2021 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/getting-ahead-of-infectious-diseases-with-advanced-technology/ Combining genetics and tech https://www.gsk.com/en-gb/behind-the-science-magazine/combining-genetics-and-tech-to-double-success-rates/ Our innovation uses human genetics, genomics and advanced technologies to develop more effective vaccines and medicines Tue, 24 Aug 2021 00:00:00 GMT https://www.gsk.com/en-gb/behind-the-science-magazine/combining-genetics-and-tech-to-double-success-rates/